INBIOGEN Co., Ltd.
101140.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.44B
Close$
$-4051.05
182.8% downside
Current Fair Value
182.8% downsideOvervalued by 182.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.44 Billion |
|---|---|
| Enterprise Value | $4.19 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $579.79 |
| Beta | 0.65 |
| Outstanding Shares | 499,238 |
Return
| Return on Equity | -14.65% |
|---|---|
| Return on Assets | -14.11% |
| Return on Invested Capital | 3.76% |
Valuation & Multiples
| P/E Ratio | -1.19 |
|---|---|
| PEG | 0.52 |
| Price to Sales | 0.48 |
| Price to Book Ratio | 0.02 |
| Enterprise Value to Revenue | 0.82 |
| Enterprise Value to EBIT | 0.79 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.98 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About INBIOGEN Co., Ltd.
41 employees
CEO: Moo-Hyung Choi Headquartered in Pyeongtaek, South Korea, INBIOGEN Co., Ltd. is a footwear manufacturer and distributor founded in 1949. The company produces and sells shoes for children, youth, and adults, serving both the South Korean domestic market ...